Tate Jeffrey Insider Trades

Insider Trading History

Track insider trading activity for Tate Jeffrey. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cyclo Therapeutics- Warrants (14/11/2025)
Cyclo Therapeutics- Warrants (14/11/2025) CYTHW
Chief Operating Officer
Holding Value $3.54k 110,732 shares
Last Trade
Jun 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 110,732 shares
$0.20
$0.03
Cyclo Therapeutics
Cyclo Therapeutics CYTH
Chief Operating Officer
Holding Value $79.8k 110,732 shares
Last Trade
Jun 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 110,732 shares
$1.28
$0.72
Cyclo Therapeutics- Warrants (14/11/2025)
Cyclo Therapeutics- Warrants (14/11/2025) CYTHW
Chief Operating Officer
Holding Value $1.05k 32,935 shares
Last Trade
Oct 20, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.2k 32,935 shares
$0.37
$0.03
Cyclo Therapeutics- Warrants (14/11/2025)
Cyclo Therapeutics- Warrants (14/11/2025) CYTHW
Chief Operating Officer
Holding Value $2.95k 92,042 shares
Last Trade
Oct 20, 2023 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$11.1k 29,941 shares
$0.37
$0.03
Cyclo Therapeutics
Cyclo Therapeutics CYTH
Chief Operating Officer
Holding Value $66.3k 92,042 shares
Last Trade
Oct 20, 2023 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$28.2k 29,941 shares
$0.94
$0.72
Cyclo Therapeutics- Warrants (14/11/2025)
Cyclo Therapeutics- Warrants (14/11/2025) CYTHW
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Oct 20, 2023 Sale (In The Money)Reported as In The Money on SEC Form 4.
$11.1k 29,941 shares
$0.37
$0.03
Cyclo Therapeutics
Cyclo Therapeutics CYTH
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Oct 20, 2023 Sale (In The Money)Reported as In The Money on SEC Form 4.
$28.2k 29,941 shares
$0.94
$0.72
Cyclo Therapeutics
Cyclo Therapeutics CYTH
Chief Operating Officer
Holding Value $23.7k 32,935 shares
Last Trade
Oct 20, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.3k 32,935 shares
$0.95
$0.72
Cyclo Therapeutics- Warrants (14/11/2025)
Cyclo Therapeutics- Warrants (14/11/2025) CYTHW
Chief Operating Officer
Holding Value $1.99k 62,101 shares
Last Trade
Apr 20, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.49k 29,941 shares
$0.25
$0.03
Cyclo Therapeutics
Cyclo Therapeutics CYTH
Chief Operating Officer
Holding Value $44.7k 62,101 shares
Last Trade
Apr 20, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.3k 29,941 shares
$0.71
$0.72
Cyclo Therapeutics- Warrants (14/11/2025)
Cyclo Therapeutics- Warrants (14/11/2025) CYTHW
Chief Operating Officer
Holding Value $958 29,941 shares
Last Trade
Apr 20, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.49k 29,941 shares
$0.25
$0.03
Cyclo Therapeutics
Cyclo Therapeutics CYTH
Chief Operating Officer
Holding Value $21.6k 29,941 shares
Last Trade
Apr 20, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.3k 29,941 shares
$0.71
$0.72
Cyclo Therapeutics- Warrants (14/11/2025)
Cyclo Therapeutics- Warrants (14/11/2025) CYTHW
Chief Operating Officer
Holding Value $1.31k 41,036 shares
Last Trade
Mar 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.1k 41,036 shares
$0.24
$0.03
Cyclo Therapeutics
Cyclo Therapeutics CYTH
Chief Operating Officer
Holding Value $29.6k 41,036 shares
Last Trade
Mar 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.3k 41,036 shares
$1.08
$0.72
Cyclo Therapeutics
Cyclo Therapeutics CYTH
Chief Operating Officer
Holding Value $23.2k 32,160 shares
Last Trade
May 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.36k 3,000 shares
$2.12
$0.72
Cyclo Therapeutics- Warrants (14/11/2025)
Cyclo Therapeutics- Warrants (14/11/2025) CYTHW
Chief Operating Officer
Holding Value $1.03k 32,160 shares
Last Trade
May 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.8k 3,000 shares
$0.60
$0.03
Cyclo Therapeutics- Warrants (14/11/2025)
Cyclo Therapeutics- Warrants (14/11/2025) CYTHW
Chief Operating Officer
Holding Value $899 28,095 shares
Last Trade
Apr 29, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$300 300 shares
$1.00
$0.03
Cyclo Therapeutics
Cyclo Therapeutics CYTH
Chief Operating Officer
Holding Value $20.2k 28,095 shares
Last Trade
Apr 29, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$810 300 shares
$2.70
$0.72
Cyclo Therapeutics
Cyclo Therapeutics CYTH
Chief Operating Officer
Holding Value $21k 29,160 shares
Last Trade
Apr 29, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.89k 1,065 shares
$2.71
$0.72
Cyclo Therapeutics- Warrants (14/11/2025)
Cyclo Therapeutics- Warrants (14/11/2025) CYTHW
Chief Operating Officer
Holding Value $933 29,160 shares
Last Trade
Apr 29, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.06k 1,065 shares
$1.00
$0.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up